2023
DOI: 10.1016/j.chembiol.2023.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Morphological subprofile analysis for bioactivity annotation of small molecules

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
54
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

5
1

Authors

Journals

citations
Cited by 18 publications
(56 citation statements)
references
References 41 publications
2
54
0
Order By: Relevance
“…By comparing the profiles of active compounds to those of reference compounds with annotated activities, target hypotheses can be derived (details in the “Experimental Section” section). In addition, a similarity to 13 biological clusters thus far can be determined by comparing CP subprofiles. , …”
Section: Resultsmentioning
confidence: 99%
“…By comparing the profiles of active compounds to those of reference compounds with annotated activities, target hypotheses can be derived (details in the “Experimental Section” section). In addition, a similarity to 13 biological clusters thus far can be determined by comparing CP subprofiles. , …”
Section: Resultsmentioning
confidence: 99%
“…the target or MoA most often associated with the compound, [52] as recently demonstrated for the NUAK1 inhibitor HTH-01-015. [49] ClogP and bpKa were calculated for the pseudo-NPs and the MIA NP reference set. Most of the pseudo-NPs (Class A = 98 %, Class B = 85 %) lie within the physicochemical parameters defined for potentially lysosomotropic compounds (Figure S14) which correlates to their high biosimilarity to the LCH cluster (Class A = 100 %, Class B = 46 %).…”
Section: Methodsmentioning
confidence: 99%
“…To facilitate the annotation of several compounds simultaneously, we have introduced a CPA subprofile analysis. [49] bioactivity clusters of compounds that share similar CPA profiles are identified, and subprofiles are produced by reducing the number of profile features to only those that are shared within a bioactivity cluster. The median features of the resulting truncated profiles are taken, resulting in a profile that is representative of a particular bioactivity cluster.…”
Section: Methodsmentioning
confidence: 99%
“…To facilitate the annotation of several compounds simultaneously, we have introduced a CPA subprofile analysis. [49] Briefly, bioactivity clusters of compounds that share similar CPA profiles are identified, and subprofiles are produced by reducing the number of profile features to only those that are shared within a bioactivity cluster. The median features of the resulting truncated profiles are taken, resulting in a profile that is representative of a particular bioactivity cluster.…”
Section: Biological Evaluation Of the Pseudo-np Collectionmentioning
confidence: 99%